NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5%
Mon, 17 Feb

NATCO PHARMA has announced its results for the quarter ended December 2019. Here is a detailed performance review of the same:

NATCO PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-18*
3
Sep-19*
3
Dec-19*
QoQ ChangeYoY Change
Net SalesRs m5,5674,8574,822-0.7%-13.4%
Other incomeRs m233332308-7.2%32.2%
TurnoverRs m5,8005,1895,130-1.1%-11.6%
ExpensesRs m3,4833,5143,5350.6%1.5%
Gross profitRs m2,0841,3431,287-4.2%-38.2%
DepreciationRs m20721925416.0%22.7%
InterestRs m636253-14.5%-15.9%
Profit before taxRs m2,0471,3941,288-7.6%-37.1%
TaxRs m45421724412.4%-46.3%
Profit after taxRs m1,5931,1771,044-11.3%-34.5%
Gross profit margin%37.427.726.7
Effective tax rate%22.215.618.9
Net profit margin%27.522.720.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 13.4% on a year-on-year (YoY) basis. The expenses were up by 1.5% YoY during the same period.
  • The company's operating profit declined by 38.2% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 26.7% in 3QFY20 as against 37.4% in 3QFY19.
  • Depreciation charges increased by 22.7% and finance costs declined by 15.9% YoY, respectively.
  • Other income increased by 32.2% YoY during the quarter.
  • Net profit for the quarter declined by 34.5% YoY. Net profit margins during the quarter declined from 27.5% in 3QFY19 to 20.4% in 3QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 0.7% on a quarter-on-quarter (QoQ) basis. The expenses were up by 0.6% QoQ during the same period.
  • The company's operating profit declined by 4.2% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 26.7% in 3QFY20 as against 27.7% in 2QFY19.
  • Net profit for the quarter declined by 11.3% QoQ, while net profit margins declined from 22.7% in 2QFY19 to 20.4% in 3QFY20.

To see how NATCO PHARMA has performed over the last eight quarters,please visit here.

FREE Event: How to Profit from the Massive Upcoming Revival in Smallcaps

NATCO PHARMA Share Price Performance

Over the last one year,NATCO PHARMA share price has moved up from Rs 594.4 to Rs 669.8, registering a Gain of Rs 75.4 or around 12.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,198.8 (down 1.5%). Over the last one year it has moved up from 13,433.0 to 14,198.8, a gain of 766 points (up 5.7%).

Overall, the S&P BSE SENSEX is up 14.4% over the year.

Current Valuations

At the current price of Rs 669.8, the price to earnings (P/E) ratio of NATCO PHARMA stands at 22.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.6 times.

Equitymaster requests your view! Post a comment on "NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5%". Click here!

  

Related Views on News

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Jan 19, 2021 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 8-QTR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS